Berberine (BBM) and Berbamine derivate (BBMD3) |
↑miR-34a-5p, miR-24-3p, miR-152, miR-429, miR-29a, miR-34a, miR-154, miR-26a, miR-124, miR-101, miR-122, miR-203 |
Inhibits snail-mediated EMT, induction of apoptosis by targeting XIAP, p53-mediated apoptosis induction, suppresses cell cycle proteins, targets cyclooxygenase-2 (COX-2), arrests cell cycle and sensitizes tumor cells to cisplatin therapy, modulates DNMTs |
NSCLC, AML, CRC, melanoma, multiple myeloma, endometrial carcinoma, oral squamous cell carcinoma, gastric carcinoma |
Zheng et al. 2020 [112], Liu et al. 2020 [113], Dong et al. 2019 [114], Yin et al. [115], Gu et al. 2017 [116], Wang et al. 2018 [117], Li et al. 2018 [118], Chen et al. 2015 [119], You et al. 2016 [120], Liu et al. 2016 [121], Huang et al. 2017 [122] |
↓miR-19a/92a, miR-106b/26, miR-93, miR106b/25 |
Camptothecin (CPT) |
↑miR-155, miR-17-5p, miR-506 |
Induces apoptosis, autophagy and triggers cell cycle arrest at G1/S phase, reduces HIF-1α protein expression and activity, sensitization of cells to apoptosis |
Myeloid leukemia, Cervical carcinoma, gastric carcinoma, CRC |
Zeng et al. 2012 [124], Bertozzi et al. 2014 [125], Cheng et al. 2015 [126], Wu et al. 2011 [127], Tong et al. 2011 [128], Huang et al. 2015 [129] |
↓miR-125b, miR-30a, miR-125b |
Inhibits apoptosis and autophagy, prevents intrinsic apoptosis |
Vincristine |
↑miR-155, miR-222-3p |
Induces apoptosis, p53 upregulation, Drug-resistance, downregulation of apoptotic pathways |
Diffuse large B-cell lymphoma, breast cancer, CRC, megakaryoblastic leukemia, ALL |
Due et al. 2019 [130], Mavrogiannis et al. 2018 [131], Dong et al. 2015 [132], Kandi et al. 2015 [133] |
↓miR-99a, miR-125b, miR-100 |